1. 790 A phase II study (TACTI-002) of eftilagimod alpha (a soluble LAG-3 protein) with pembrolizumab in PD-L1 unselected patients with metastatic non-small cell lung(NSCLC) or head and neck carcinoma(HNSCC). (10th December 2020) Authors: Krebs, Matthew; Majem, Margarita; Felip, Enriqueta; Forster, Martin; Doger, Bernard; Clay, Tim; Carcereny, Enric; Peguero, Julio; Horn, Leora; Bajaj, Pawan; Roxburgh, Patricia; Brignone, Chrystelle; Mueller, Christian; Triebel, Frederic Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A472 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 790 A phase II study (TACTI-002) of eftilagimod alpha (a soluble LAG-3 protein) with pembrolizumab in PD-L1 unselected patients with metastatic non-small cell lung(NSCLC) or head and neck carcinoma(HNSCC). (9th November 2020) Authors: Krebs, Matthew; Majem, Margarita; Felip, Enriqueta; Forster, Martin; Doger, Bernard; Clay, Tim; Carcereny, Enric; Peguero, Julio; Horn, Leora; Bajaj, Pawan; Roxburgh, Patricia; Brignone, Chrystelle; Mueller, Christian; Triebel, Frederic Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A839 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Talking to young children about war. (2nd June 2022) Authors: Forster, Martin Journal: Early years educator Issue: Volume 23:Number 11(2022) Page Start: 6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 study. Issue 6 (June 2022) Authors: Zauderer, Marjorie G; Szlosarek, Peter W; Le Moulec, Sylvestre; Popat, Sanjay; Taylor, Paul; Planchard, David; Scherpereel, Arnaud; Koczywas, Marianna; Forster, Martin; Cameron, Robert B; Peikert, Tobias; Argon, Evren Kocabaş; Michaud, Neil R; Szanto, Attila; Yang, Jay; Chen, Yingxue; Kansra, Vik... Journal: Lancet oncology Issue: Volume 23:Issue 6(2022) Page Start: 758 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Feasibility and implementation of Safer Kids – A parenting program to reduce child abuse. (January 2022) Authors: van Leuven, Livia; Lalouni, Maria; Enebrink, Pia; Sorjonen, Kimmo; Forster, Martin Journal: Child abuse & neglect Issue: Volume 123(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Biases in bias elicitation. Issue 18 (17th September 2019) Authors: Manzi, Giancarlo; Forster, Martin Journal: Communications in statistics Issue: Volume 48:Issue 18(2019) Page Start: 4656 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A comparison of Bayesian and non-linear regression methods for robust estimation of pharmacokinetics in DCE-MRI and how it affects cancer diagnosis. (March 2017) Authors: Dikaios, Nikolaos; Atkinson, David; Tudisca, Chiara; Purpura, Pierpaolo; Forster, Martin; Ahmed, Hashim; Beale, Timothy; Emberton, Mark; Punwani, Shonit Journal: Computerized medical imaging and graphics Issue: Volume 56(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. CONCORDE: a phase Ib platform study of novel agents in combination with conventional radiotherapy in non-small cell lung cancer (NSCLC). (March 2022) Authors: Horne, Ashley; Ali, Aaisha; Brown, Sarah; Butterworth, Karl; Chalmers, Anthony; Clipson, Alexandra; Collinson, Fiona; Dive, Caroline; Faivre-Finn, Corinne; Forster, Martin; Franks, Kevin; Gilbert, Alexandra; Hanna, Gerry; Hannaway, Nicola; Harrow, Stephen; Hartley, John; Hiley, Crispin; Jones, Ro... Journal: Lung cancer Issue: Volume 165(2022)Supplement 1 Page Start: S69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. SARON: stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer (NSCLC). (March 2022) Authors: Mak, Ka-Man; McDonald, Fiona; Teague, Jonathan; Faivre-Finn, Corinne; Forster, Martin; Hanna, Gerard; Moinuddin, Syed; Conibear, John; Harden, Susan; Popat, Sanjay; Califano, Raffaele; Farrelly, Laura; Counsell, Nicholas; TMG, Saron Journal: Lung cancer Issue: Volume 165(2022)Supplement 1 Page Start: S71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Tepotinib in patients with MET exon 14 (METex14) skipping NSCLC: results from the VISION study and local UK experience. (March 2022) Authors: Cui, Wanyuan; Brown, Nick; Brown, Victoria; Bulusu, Ramesh; Denton, Arshi; Evans, Joanne; Forster, Martin; Papadatos-Pastos, Dionysis; Pellegrino, Loredana; Walsh, Nessa; Bruns, Rolf; Otto, Gordon; Paik, Paul Journal: Lung cancer Issue: Volume 165(2022)Supplement 1 Page Start: S38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗